SKBI Share Price

Open 0.01 Change Price %
High 0.01 1 Day 0.00 0.00
Low 0.01 1 Week 0.00 0.00
Close 0.01 1 Month 0.01 0.00
Volume 400 1 Year -0.15 -93.75
52 Week High 0.30
52 Week Low 0.00
SKBI Important Levels
Resistance 2 0.01
Resistance 1 0.01
Pivot 0.01
Support 1 0.01
Support 2 0.01
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
More..
NASDAQ USA Top Gainers Stocks
AMCF 0.02 100.00%
RITT 0.02 100.00%
LOCM 0.09 50.00%
SCHS 0.04 33.33%
GEVO 0.81 32.79%
MRGE 0.55 30.95%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
CYCC 2.24 21.74%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
ULTR 0.05 -37.50%
More..

Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI)

SKBI Technical Analysis 5
As on 12th Sep 2017 SKBI Share Price closed @ 0.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.15 & Strong Sell for SHORT-TERM with Stoploss of 0.05 we also expect STOCK to react on Following IMPORTANT LEVELS.
SKBI Target for September
1st Target up-side 0.05
2nd Target up-side 0.07
3rd Target up-side 0.09
1st Target down-side -0.01
2nd Target down-side -0.03
3rd Target down-side -0.05
SKBI Other Details
Segment EQ
Market Capital 14449120.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.skystarbio-pharmaceutical.com
SKBI Address
SKBI
Building B
4th Floor
Xi,
China
Phone: 86 29 8819 3188
SKBI Latest News
Interactive Technical Analysis Chart Skystar Bio-Pharmaceutical Company ( SKBI NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Skystar Bio-Pharmaceutical Company
SKBI Business Profile
Skystar Bio-Pharmaceutical Company (Skystar) is a holding company. The Company is engaged in the research, development, production, marketing, and sales of veterinary healthcare and medical care products. It has four product lines: micro-organism products line, which include over 16 products; veterinary medicine line for poultry and livestock, which includes over 245 products; feed additives line, which includes over 16 products, and bio-pharmaceutical veterinary vaccine line, which includes over 10 products. All of the Company�s operations are carried out by Xi�an Tianxing Bio-Pharmaceutical Co., Limited (Xi�an Tianxing), a People�s Republic of China (PRC) joint stock company that the Company controls through contractual arrangements originally between Skystar Bio-Pharmaceutical (Cayman) Holdings Co., Ltd. (Skystar Cayman) and Xi�an Tianxing. As of December 31, 2011, it had over 3,846 customers in 29 provinces in China.